AIRLINK 177.92 Increased By ▲ 0.92 (0.52%)
BOP 12.88 Increased By ▲ 0.07 (0.55%)
CNERGY 7.58 Increased By ▲ 0.09 (1.2%)
FCCL 45.99 Increased By ▲ 3.97 (9.45%)
FFL 15.16 Increased By ▲ 0.32 (2.16%)
FLYNG 27.34 Decreased By ▼ -0.36 (-1.3%)
HUBC 132.04 Decreased By ▼ -2.47 (-1.84%)
HUMNL 13.29 Increased By ▲ 0.33 (2.55%)
KEL 4.46 Increased By ▲ 0.02 (0.45%)
KOSM 6.06 No Change ▼ 0.00 (0%)
MLCF 56.63 Increased By ▲ 2.12 (3.89%)
OGDC 223.84 Increased By ▲ 1.26 (0.57%)
PACE 5.99 Decreased By ▼ -0.04 (-0.66%)
PAEL 41.51 Increased By ▲ 0.21 (0.51%)
PIAHCLA 16.01 Increased By ▲ 0.39 (2.5%)
PIBTL 9.88 Decreased By ▼ -0.18 (-1.79%)
POWER 11.16 Decreased By ▼ -0.01 (-0.09%)
PPL 186.63 Increased By ▲ 2.64 (1.43%)
PRL 34.90 Increased By ▲ 0.59 (1.72%)
PTC 23.53 Increased By ▲ 0.19 (0.81%)
SEARL 94.96 Increased By ▲ 3.89 (4.27%)
SILK 1.14 Increased By ▲ 0.03 (2.7%)
SSGC 35.50 Increased By ▲ 1.52 (4.47%)
SYM 15.64 Decreased By ▼ -0.32 (-2.01%)
TELE 7.87 Increased By ▲ 0.01 (0.13%)
TPLP 10.93 Decreased By ▼ -0.08 (-0.73%)
TRG 59.20 Increased By ▲ 0.48 (0.82%)
WAVESAPP 10.78 Decreased By ▼ -0.01 (-0.09%)
WTL 1.35 Decreased By ▼ -0.01 (-0.74%)
YOUW 3.80 Decreased By ▼ -0.01 (-0.26%)
AIRLINK 177.92 Increased By ▲ 0.92 (0.52%)
BOP 12.88 Increased By ▲ 0.07 (0.55%)
CNERGY 7.58 Increased By ▲ 0.09 (1.2%)
FCCL 45.99 Increased By ▲ 3.97 (9.45%)
FFL 15.16 Increased By ▲ 0.32 (2.16%)
FLYNG 27.34 Decreased By ▼ -0.36 (-1.3%)
HUBC 132.04 Decreased By ▼ -2.47 (-1.84%)
HUMNL 13.29 Increased By ▲ 0.33 (2.55%)
KEL 4.46 Increased By ▲ 0.02 (0.45%)
KOSM 6.06 No Change ▼ 0.00 (0%)
MLCF 56.63 Increased By ▲ 2.12 (3.89%)
OGDC 223.84 Increased By ▲ 1.26 (0.57%)
PACE 5.99 Decreased By ▼ -0.04 (-0.66%)
PAEL 41.51 Increased By ▲ 0.21 (0.51%)
PIAHCLA 16.01 Increased By ▲ 0.39 (2.5%)
PIBTL 9.88 Decreased By ▼ -0.18 (-1.79%)
POWER 11.16 Decreased By ▼ -0.01 (-0.09%)
PPL 186.63 Increased By ▲ 2.64 (1.43%)
PRL 34.90 Increased By ▲ 0.59 (1.72%)
PTC 23.53 Increased By ▲ 0.19 (0.81%)
SEARL 94.96 Increased By ▲ 3.89 (4.27%)
SILK 1.14 Increased By ▲ 0.03 (2.7%)
SSGC 35.50 Increased By ▲ 1.52 (4.47%)
SYM 15.64 Decreased By ▼ -0.32 (-2.01%)
TELE 7.87 Increased By ▲ 0.01 (0.13%)
TPLP 10.93 Decreased By ▼ -0.08 (-0.73%)
TRG 59.20 Increased By ▲ 0.48 (0.82%)
WAVESAPP 10.78 Decreased By ▼ -0.01 (-0.09%)
WTL 1.35 Decreased By ▼ -0.01 (-0.74%)
YOUW 3.80 Decreased By ▼ -0.01 (-0.26%)
BR100 12,130 Increased By 107.3 (0.89%)
BR30 37,246 Increased By 640.2 (1.75%)
KSE100 114,399 Increased By 685.5 (0.6%)
KSE30 35,458 Increased By 156.2 (0.44%)

President Dr Arif Alvi Sunday said that Pakistan was on tipping point of socioeconomic development and it was high time for all the citizens to play their role to uplift country's poor by providing them education, health and other opportunities equally. Addressing a National Conference themed 'Invest in Eliminating Hepatitis from Pakistan' in connection with the World Hepatitis Day annually observed on July 28, the president said the prevalence of hepatitis B and C in 15 to 20 million people of Pakistan was alarming.
The event was attended by Special Assistant to Prime Minister on Health Dr Zafar Mirza, Regional Director WHO Dr Ahmed Salim Al-Mandhari, Assistant Director General Universal Health Coverage, WHO Dr Ren Minghui and health experts from various local and international institutions. He said the vehicle to transmit the virus of both hepatitis and HIV were same like the unsafe blood transfusion and reuse of syringes which needed to be tackled to avert any volcanic situation.
He said Egypt had brought down the hepatitis prevalence from 13 percent to 3 percent in just 10 years and it was also doable for Pakistan. However, the president strongly advocated for focused efforts on prevention of the diseases terming it far cheaper than the cure.
The conference marked the launching of Prime Minister's Policy Package for Elimination of Viral Hepatitis from Pakistan that would ensure the screening of around 140 million people for hepatitis and provide free medical treatment of those found infected. According to data, with 10 percent HCV prevalence, about 20 million would be anti HCV positive and would go necessary screening. Almost 80 percent would show the virus and need treatment. Using these estimates, around 16 million cases would need Direct Acting Antivirals and 12 million would be cured.
The president said unfortunately, the health practitioners were not being taught to treat the patients prescribing the minimum possible medicines particularly the antibiotics and injections. He said the awareness against the viral diseases like hepatitis and HIV could be better created through physical interactions like the lady health workers, besides using the electronic and social media, NGOs and regular seminars.
He said laudably, Pakistan had been trying to eliminate the viral disease despite resource constraints and added that investment in education and health sectors could lead the country to a real change and achievement of Naya Pakistan. Addressing the conference, Dr Zafar Mirza said that thousands of new hepatitis patients were being added every year due to lack of prevention, testing and treatment resources as well as inadequately screened blood transfusion, improperly sterilised invasive medical devices and unsafe injections.
He said the PM's ambitious plan to eliminate viral hepatitis B and C infections in the country by 2030 was aimed at providing leadership and coordination to provincial programmes in scaling up hepatitis prevention, testing and treatment services. In an eye-opening revelation, Dr Mirza said above eight injections per capita are given in Pakistan with around 95 percent of those being unnecessary.
He said Pakistan had the highest ratio of hepatitis prevalence in the world. Most of the factors spreading the virus were originating from the healthcare system including the unsafe blood transfusion and reuse of syringes, he added. Mirza said a National Blood Service would be developed to ensure transfusion of 100 percent screened blood and the target would be achieved within this government.
He also expressed the commitment to redesign the Hepatitis Control Programme in the spirit of the 18th amendment as it had weakened after the devolution. Moreover, a disease surveillance system would be developed to collect the real time data for early intervention. The Special Assistant to PM said in order to purge the country of these deadly diseases, it was inevitable to depoliticise the health sector and make concerted efforts considering it a humanitarian cause.
Although Pakistan produces cheaper medicines to cure hepatitis C infection, with a very low cost per cure within three months, very few people in the country know of their infection, and therefore, do not access testing and treatment services. The cost of cure for hepatitis C could be as high as US$15,000 in a country like the US. According to WHO, 23,720 people died of hepatitis-related causes in Pakistan in 2016, which compares to a bus full of 64 people every day.
The WHO expressed its full support to the Government of Pakistan in implementing its plans to eliminate hepatitis B and C epidemics. In his video message, WHO's Director-General Dr Tedros Adhanom Ghebreyesus congratulated Pakistan's high political leadership and the Prime Minister's initiatives to eliminate the hepatitis by 2030.
The WHO Assistant Director-General for Universal health coverage for communicable and non-communicable diseases, Dr Ren Minghui underlined the importance of using integrated approaches and many existing opportunities and innovations that can support Pakistan achieve its ambitious but necessary goals. The Regional Director of WHO EMRO Dr Ahmed Salim Saif Al-Mandhari also acknowledged Pakistan's political leadership in responding to its hepatitis scourge, and said that Pakistan's efforts would help strengthen basic health systems in the country and could serve as a positive example for other countries in the region, which had the highest prevalence of hepatitis C in the world and ranking second in prevalence of hepatitis B.
During the two-day conference, the provincial health ministers and secretaries, provincial hepatitis control programme managers, members of National Technical Advisory Group, experts from Aga Khan University, researchers, policy makers and civil society activists also pledged their support to the cause.

Copyright Associated Press of Pakistan, 2019

Comments

Comments are closed.